Knight Therapeutics | GUD - Capitalização De Mercado

Preço das Ações
7.20
Mudança Diária
0.12 1.69%
Mensal
13.56%
Anual
18.23%
Q1 Previsão
7.02




Capitalização De Mercado Alterar Data
Akebia Therapeutics USD 312M 115M 2026-03
Alaunos Therapeutics USD 51M 46M 2026-03
Aurora Cannabis CAD 258.86M 68.36M 2026-03
Avita Medical AUD 164.6M 59.13M 2026-03
Canopy Growth CAD 125.74M 530.72M 2026-03
Cronos Group USD 1.35B 350.25M 2026-03
Dianthus Therapeutics USD 2.32B 535M 2026-03
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
IQVIA Holdings USD 38.39B 6.1B 2025-12
Knight Therapeutics CAD 625.23M 24.71M 2026-03
Organigram Holdings CAD 174.77M 137.39M 2026-03
Organon & Co USD 1.86B 916.43M 2025-12
Revvity USD 10.97B 1.21B 2025-12
Tectonic Therapeutic USD 474M 84M 2026-03
Tilray USD 6.71B 5.76B 2026-03
Viatris USD 14.34B 2.8B 2025-12
Xeris Pharmaceuticals USD 788M 515M 2026-03